Maravai Lifesciences Holdings, Inc. Class A MRVI 深 滬
等待開盤 02-11 09:30:00 美东时间
3.12
+0.010
+0.32%
華盛通- 最 高3.21
- 今 開3.11
- 成交量 71.43万股
- 最 低 3.09
- 昨 收 3.11
- 總市值 7.98亿
- 52周最高 4.215
- 市盈率 靜 --
- 換手率 0.28%
- 52周最低 1.665
- 委 比 74.51%
- 總股本 2.56亿
- 歷史最高 63.55
- 量 比 0.59
- 振 幅 3.86%
- 歷史最低 1.665
- 每 手 1
- 風險率 0.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Maravai LifeSciences Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen an
Maravai LifeSciences Holdings Inc. kündigt Veröffentlichung von Finanzergebnissen an Maravai LifeSciences Holdings Inc. wird die Finanz- und Betriebsergebnisse für das vierte Quartal und das Gesamtjahr 2025 am Mittwoch, den 25. Februar 2026, nach Börsenschluss veröffentlichen. Die Ergebnisse werden
02-10 06:05
Maravai LifeSciences Holdings Inc. to Announce Financial and Operating Results and Host Earnings Call
Maravai LifeSciences Holdings Inc. to Announce Financial and Operating Results and Host Earnings Call Maravai LifeSciences Holdings Inc. will announce its fourth quarter and full year 2025 financial and operating results after the market close on Wednesday, February 25, 2026. The results will be rel
02-10 06:05
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5
Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4 to $4.5.
2025-12-16 02:25
Maravai LifeSciences Holdings shares are trading lower after the company reported worse-than-expected Q3 sales results.
Maravai LifeSciences Holdings shares are trading lower after the company report...
2025-11-07 05:58
Maravai LifeSciences Q3 Adj. EPS $(0.08), Inline, Sales $41.630M Miss $49.003M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 700 percent decrease over losses of $(0.01) per share from the same period last year.
2025-11-07 05:04
Avantor® Appoints Gregory T. Lucier to its Board of Directors
Brings more than three decades of leadership experience in the life sciences industry RADNOR, Pa., Oct. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of missi...
2025-10-03 20:05
Goldman's 48 potential M&A candidates
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
2025-09-29 03:14
美股牛股 | 多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%
多只绩优股狂飙！Rumbleon涨超60%，Tonix制药控股涨超32%；美国7月机票价格创3年多来最大月度涨幅！美国航空股Frontier Group涨近30%>>
2025-08-13 15:56
Maravai生命科学宣布削减成本计划
Maravai生命科学公司（Maravai LifeSciences，MRVI）周二宣布了一项年度化5000万美元的成本削减计划，目标是到2026年实现E...
2025-08-12 22:57
